| Metric | სს მეგა-ლაბი | შპს ფარმაქსი |
|---|---|---|
| Growth | ||
| Revenue | ₾18.4m₾20.4m | ₾37.2m₾38.4m |
| Revenue growth | -9.8% | -2.9% |
| Profitability | ||
| EBITDA | ₾936k-₾393k | ₾2.3m₾4.9m |
| EBITDA margin | 5.1%-1.9% | 6.1%12.8% |
| Net profit | -₾1.2m-₾2.6m | ₾188k₾5.6m |
| Net margin | -6.4%-12.7% | 0.5%14.6% |
| Balance sheet | ||
| Total assets | ₾27.8m₾25.4m | ₾53.9m₾85.6m |
| Total equity | ₾15.5m₾16.4m | ₾17.6m₾28.0m |
| ROE | -7.5%-15.8% | 1.1%20.0% |